%0 Journal Article
%T Immunological alterations in the endothelial barrier: a new predictive and therapeutic paradigm for sepsis.
%A Feng J
%A Liu L
%A Liu J
%A Wang J
%J Expert Rev Clin Immunol
%V 0
%N 0
%D 2024 Jun 11
%M 38850066
%F 5.124
%R 10.1080/1744666X.2024.2366301
%X <B>UNASSIGNED: </B>Despite the fact incidence and mortality vary widely among regions, sepsis remains a major cause of morbidity and cost worldwide. The importance of the endothelial barrier in sepsis and infectious diseases is increasingly recognized; however, the underlying pathophysiology of the endothelial barrier in sepsis remains poorly understood.<BR><B>UNASSIGNED: </B>Here we review the advances in basic and clinical research for relevant papers in PubMed database. We attempt to provide an updated overview of immunological alterations in endothelial dysfunction, discussing the central role of endothelial barrier involved in sepsis to provide new predictive and therapeutic paradigm for sepsis.<BR><B>UNASSIGNED: </B>Given its physiological and immunological functions in infectious diseases, the endothelial barrier has been dramatically altered in sepsis, suggesting that endothelial dysfunction may play a critical role in the pathogenesis of sepsis. Although many reliable biomarkers have been investigated to monitor endothelial activation and injury in an attempt to find diagnostic and therapeutic tools, there are no specific therapies to treat sepsis due to its complex pathophysiology. Since sepsis is initiated by both hyperinflammation and immunoparalysis occurring simultaneously, a 'one-treatment-fits-all' strategy for sepsis-induced immune injury and immunoparalysis is bound to fail, and an individualized 'precision medicine' approach is required.